The Ninth Annual Rutgers Brain Health Institute Symposium will be held on Thursday, November 30, 2023 at the Douglass Student Center in New Brunswick, NJ. It will feature talks by Rutgers faculty presenting their cutting-edge research. The afternoon session includes student/post-doc poster presentations with cash awards to the top three best posters. CLICK HERE to register.

The student/post-doc poster session on neuroscience & brain health research and award ceremony will wrap up the symposium. This year, the top three posters at the symposium will be awarded $200, $150, and $100, respectively. Trainees, you can’t win unless you participate; so, don’t forget to register and submit your abstracts by November 3, 2023. Due to space limitations, we can only accept about 50 posters on neuroscience and brain health related research. We request one poster submission per lab. We will accept posters from the first 50 trainees who register online.

The symposium will feature talks by new BHI faculty whose research spans basic, translational, and clinical neuroscience. The keynote speaker is Dr. Michael Shadlen from Columbia University. Mike is an Investigator of the Howard Hughes Medical Research Institute and Professor of Neuroscience at Columbia University Medical School. He is a member of the Mortimer B. Zuckerman Mind Brain Behavior Institute (ZI) and the Kavli Institute of Brain Science. Dr. Shadlen obtained his undergraduate and medical degrees at Brown University, PhD at UC Berkeley with Ralph Freeman, and post-doc training in clinical neurology at Stanford University with William Newsome. His research focuses primarily on the neural mechanisms that underlie decision making. He is also a jazz guitarist and co-curates the Jazz Artist in Residence program at ZI. Honors include the Alden Spencer Prize, Golden Brain, Lashley Award, and elections to the AAAS, National Academy of Medicine, and the National Academy of Sciences.

Keeping with the clinical neuroscience theme, the afternoon session at the symposium will feature Dr. Michal Beeri, the newly recruited Director of the Krieger Klein Alzheimer and Dementia Clinical Research & Treatment Center in BHI, as well as presentations by Rey Panettieri, MD and Nancy Reilly, RN on resources available for clinical neuroscience research via the NJACTS – CTSA and RBHS Clinical Trials Office.